Joint European Commission (EC) / European Medicines Agency (EMA) multi-stakeholder workshop on regulatory sandbox

Discussion of aspects of the implementation of EU regulatory sandboxes as laid out in the revised pharmaceutical legislation.

German is available via eTranslation, the European Commission's machine translation service.

Translate to German | Important information about machine translation

Date

, -

Ort

Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast

Event summary

A regulatory sandbox establishes a time-limited framework in which developers can design, validate, and test innovative medicines or methodologies in a controlled, real-world environment, under strict regulatory oversight.

The reform of the EU pharmaceutical legislation includes regulatory sandboxes as a tool to test, under the direct supervision of the competent authorities, adapted requirements for innovative medicines that cannot be developed under current rules.

The aim of this workshop is to discuss aspects of the implementation of EU regulatory sandboxes as laid out in the revised pharmaceutical legislation, how sandboxes work, and what is necessary to implement and execute them effectively.

Documents

Registration

Registration by invitation only.

Video recording is published after the event.

Live broadcast

 

Video quality

To view the video in the highest quality, click Settings in the bottom right-hand corner of the video and select High.

To watch the video in full screen mode, click the arrow icon to watch it on Panopto.

Share this page